Reanalysis of microarray data reveals insights into altered transcriptional activity of T helper 17 and regulatory T cell signaling in psoriasis

References

• Morris PE, Omura GA. Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis. Curr Pharm Des. 2000;6:943–959.
   PubMed Web of Science ®Google Scholar
• Romanowska M, Yacoub NA, Seidel H, et al. PPARS enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Dermatol. 2008;128:110–124.
   Web of Science ®Google Scholar
• Madsen P, Rasmussen HH, Leffers H, Honoré B, Celis JE. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J Invest Dermatol. 1992;99:299–305.
   PubMed Web of Science ®Google Scholar
• Rittner C, Bertrams J. On the significance of C2, C4, and factor B polymorphisms in disease. Hum Genet. 1981;56:235–247.
   PubMed Web of Science ®Google Scholar
• Schlattner U, Möckli N, Speer O, Werner S, Wallimann T. Creatine kinase and creatine transporter in normal, wounded, and diseased skin. J Invest Dermatol. 2002;118:416–423.
   PubMed Web of Science ®Google Scholar
• Gudjonsson JE, Ding J, Johnston A, et al. Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol. 2010;130:1829–1840.
   PubMed Web of Science ®Google Scholar
• Mee JB, Johnson CM, Morar N, Burslem F, Groves RW. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes dominance of innate immune responses in psoriasis. Am J Pathol. 2007;171:32–42.
   PubMed Web of Science ®Google Scholar
• Koczan D, Guthke R, Thiesen H, et al. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol. 2005;15:251–257.
   Web of Science ®Google Scholar
• Romanowska M, Evans A, Kellock D, et al. Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon. P LoS One. 2009;4:e5354.
   Web of Science ®Google Scholar
• Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM. Early gene changes induced by isotretinoin in the skin provide clues to its mechanism of action. Dermatoendocrinol. 2009;1:100–101.
   PubMedGoogle Scholar
• Lee S, Kim B, Seo S, et al. Gene expression profile in fetal bovine serum-induced abnormal differentiation of skin keratinocytes. Korean J Invest Dermatol. 2006;126:125–133.
   Google Scholar
• Haider AS, Peters SB, Kaporis H, et al. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol. 2006;126:869–881.
   PubMed Web of Science ®Google Scholar
• Ding J, Gudjonsson JE, Liang L, et al. Gene expression in skin and lymphoblastoid cells: refined statistical method reveals extensive overlap in cis-eQTL signals. Am J Hum Genet. 2010;87:779–789.
   Web of Science ®Google Scholar
• Li Y, Liao W, Cargill M, et al. Carriers of rare missense variants in IFIH1 are protected from psoriasis. J Invest Dermatol. 2010;130:2768–2772.
   PubMed Web of Science ®Google Scholar
• Bruch-Gerharz D, Schnorr O, Suschek C, et al. Arginase 1 overexpression in psoriasis limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol. 2003;12:203–211.
   Google Scholar
• Wongpiyabovorna J, Sutoa H, Ushiob H, et al. Up-regulation of interleukin-13 receptor a1 on human keratinocytes in the skin of psoriasis and atopic dermatitis. J Dermatol Sci. 2003;33:31–40.
   Web of Science ®Google Scholar
• Taylor JM, Street TL, Hao L, et al. Dynamic and physical clustering of gene expression during epidermal barrier formation in differentiating keratinocytes. P LoS One. 2009;4:e7651.
   Web of Science ®Google Scholar
• Gudmundsdottir AS, Sigmundsdottir H, Sigurgeirsson B, Good MF, Valdimarsson H, Jonsdottir I. Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol. 1999;117:580–586.
   PubMed Web of Science ®Google Scholar
• Mommers JM, van Rossum MM, van Erp PE, van De Kerkhof PC. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology. 2000;201:15–20.
   Web of Science ®Google Scholar
• Iwakiri K, Ghazizadeh M, Jin E, et al. Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. J Invest Dermatol. 2004;122:937–944.
   PubMed Web of Science ®Google Scholar
• Yao Y, Richman L, Morehouse C, et al. Type I interferon: potential therapeutic target for psoriasis? P LoS One. 2008;16:e2737.
   Google Scholar
• Suarez-Farinas M, Magnasco MO. Comparing microarray studies. Methods Mol Biol. 2007;377:139–152.
   Google Scholar
• Bowcock AM, Shannon W, Du F, et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet. 2001;10:1793–1805.
   PubMed Web of Science ®Google Scholar
• Zhou X, Krueger JG, Kao MJ, et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucteotide array. Physiol Genomics. 2003;13:69–78.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Warren D, Spencer F, et al. Multiple-laboratory comparison of microarray platforms. Nat Methods. 2005;2:345–350.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, Baliga NS, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
   PubMed Web of Science ®Google Scholar
• Haider AS, Lowes MA, Suàrez-Farinas M, et al. Identification of cellular pathways of “Type 1,” Th17 T Cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol. 2008;180:1913–1920.
   PubMed Web of Science ®Google Scholar
• Oestreicher JL, Walters IB, Kikuchi T, et al. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics. 2001;1:272–287.
   Google Scholar
• Reischl J, Schwenke S, Beekman JM, et al. Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol. 2007;127:163–169.
   PubMed Web of Science ®Google Scholar
• Nair RP, Duffin KC, Helms C, et al. Genome wide scan reveals association of psoriasis with IL-23 and NF-kB pathways. Nat Genet. 2009;41:199–204.
   PubMed Web of Science ®Google Scholar